The role of MHC class I expression in rat NK cell-mediated lysis of syngeneic tumor cells and virus-infected cells

Immunobiology

Volumn 195, Issue 3, 1996, Pages 286-299

  Giezeman Smits, Katinka M ^a   Kuppen, Peter J K ^a,b   Ensink, N Geeske ^a,b   Eggermont, Alexander M M ^c   Stals, Frans ^d   Wonigeit, Kurt ^e   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHROMIUM 51; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS; EMBRYO; FIBROBLAST; FLOW CYTOMETRY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL DESTRUCTION; VIRUS INFECTION;

EID: 0029813059     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80046-5     Document Type: Article

References (36)

1. SPERLING, A. I., and J. A. BLUESTONE. 1993. Non-classical MHC molecules: The first line of defence. Curr. Biol. 3: 294.
2. HERBERMAN, R. B., and J. R. ORTALDO. 1981. Natural killer cells: their role in defense against disease. Science. 214: 24.
3. VUJANOVIC, N. L., R. B. HERBERMAN, and J. C. HISERODT. 1988. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Cancer Res. 48: 878.
4. LJUNGGREN, H.-G., and K. KÄRRE. 1990. In search of the «missing self»: MHC molecules and NK cell recognition. Immunol. Today 11: 237.
5. KÄRRE, K. 1995. Express yourself or die: peptides, MHC molecules, and NK cells. Science 267: 978.
6. MAUDSLEY, D. J., and J. D. POUND. 1991. Modulation of MHC antigen expression by viruses and oncogenes. Immunol. Today 12: 429.
7. SCHRIER, P. I., R. BERNARDS, R. T. M. J. VAESSEN, A. HOUWELING, and A. J. VAN DER EB. 1983. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cell. Nature 305: 771.
8. LJUNGGREN, H.-G., K STURMHÖFEL, E. WOLPERT, G. J. HÄMMERLING, and K. KÄRRE. 1990. Transfection of β2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. J. Immunol. 145:3-80.
9. JABRANE-FERRAT, N., F. CALVO, A. FAILLE, J. F. LAGABRIELLE, N. BOISSON, A. QUILLET, and D. FRADELIZI. 1990. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicty. Br. J. Cancer. 61: 558.
10. YOKOYAMA, W. M. 1995. Natural killer cell receptors. Curr. Opin. Immunol. 7: 100.
11. YOKOYAMA, W. M. 1995. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Proc. Natl. Acad. Sci. USA. 92: 3081.
12. GUMPERZ, J. E., V. LITWIN, J. H. PHILLIPS, L. L. LANIER, and P. PARHAM. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181: 1133.
13. MALNATI, M. S., M. PERUZZI, K. C. PARKER, W. E. BIDDISON, E. CICCONE, A. MORETTA, and E. O. LONG. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267: 1016.
14. CORTESE HASSET, A. L., D. N. MISRA, H. W. KUNZ, and T. J. GILL III. 1991. Immunogenetics of the Major Histocompatibility Complex, 309 pp.
15. FUKUMOTO, T., W. R. MCMASTER, and A. F. WILLIAMS. 1982. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur. J. Immunol. 12: 237.
16. PARKER, K. E., C. A. CARTER, and J. W. FABRE. 1990. A rat class I cDNA clone with an Alu-like sequence and mapping to two genes in RT1.C/E. Immunogenetics 31: 211.
17. BRIDEAU, R. J., P. B. CARTER, W. R. MCMASTER, D. W. MASON, and A. F. WILLIAMS. 1980. Two subsets of rat lymphocytes defined with monoclonal antibodies. Eur. J. Immunol. 10: 609.
18. BEUN, G. D. M., J. D. H. VAN EENDENBURG, W. E. CORVER, C. J. H. VAN DE VELDE, and G. J. FLEUREN. 1992. T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized anti-T-cell receptor antibody. J. Immunother. 11: 238.
19. SCHULZE, F., M. WINKLER, R. SCHWINZER, and K. WONIGEIT. 1990. Expression of RT1.C antigens on lymphoid cells: analysis by monoclonal antibodies. Transplant. Proc. 22: 2514.
20. KUPPEN, P. J. K., A. M. M. EGGERMONT, K. M. SMITS, J. D. H. VAN EEDENBURG, S. P. G. LAZEROMS, C. J. H. VAN DE VELDE, and G. J. FLEUREN. 1993. The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531. Cancer Immunol. Immunother. 36: 403.
21. MARQUET, R. L., D. L. WESTBROEK, and J. JEEKEL. 1984. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int. J. Cancer. 33: 689.
22. SMITS, K. M., P. J. K. KUPPEN, A. M. M. EGGERMONT, and G. J. FLEUREN. 1994. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells. Eur. J. Immunol. 24: 171.
23. KLOOSTERMAN, T. C., M. J. C. TIELEMANS, A. C. M. MARTENS, M. HOOGERBRUGGE, D. W. VAN BEKKUM, and A. HAGENBEEK. 1992. L4415: Further characterization of the rat model for human acute lymphocytic leukemia. Leukemia 6: 1161.
24. VAN DER MEIDE, P. H., M. DUBBELD, K. VIJVERBERG, T. KOS, and H. SCHELLEKENS. 1986. The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J. Gen. Virol. 67: 1059.
25. STALS, F. S., F. BOSMAN, C. P. VAN BOVEN, and C. A. BRUGGEMAN. 1990. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch. Virol. 114: 91.
26. BRUGGEMANN, C. A., H. MEIJER, P. H. J. DORMANS, W. M. H. DEBIE, G. E. L. M. GRAULS, and C. P. A. VAN BOVEN. 1982. Isolation of a cytomegalovirus-like agent from wild rats. Arch. Virol. 73: 231.
27. BRUGGEMANN, C. A., H. MEIJER, F. BOSMAN, and C. P. VAN BOVEN. 1985. Biology of rat cytomegalovirus infection. Intervirology 24: 1.
28. STALS, F. S., E. DE CLERCQ, and C. A. BRUGGEMAN. 1991. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo. Antimicrob. Agents. Chemother. 35: 2262.
29. CARBONE, E., L. RACIOPPI, A. LA CAVA, G. PORTELLA, F. VELOTTI, S. ZAPPACOSTA, and S. FONTANA. 1991. NK and LAK susceptibility varies inversely with target cell MHC class I antigen expression in a rat epithelial tumour system. Scand. J. Immunol. 33: 185.
30. NAPER, C., J. T. VAAGE, D. LAMBRACHT, G. LOVIK, G. W. BUTCHER, K. WONIGEIT, and B. ROLSTAD. 1995. Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control. Eur. J. Immunol. 25: 1249.
31. 1 and two other class I genes of the rat MHC. Immunogenetics 41: 375.
32. BUKOWSKI, J. F., and R. M. WELSH. 1985. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. J. Immunol. 135: 3537.
33. BROWNE, H., G. SMITH, S. BECK, and T. MINSON. 1990. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta-2 microglobulin. Nature 347: 770.
34. SPRINGER, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425.
35. TORRES-NAGEL, N., E. KRAUS, M. H. BROWN, G. TIEFENTHALTER, R. MITNACH, A. F. WILLIAMS, and T. HÜNIG. 1992. Differential thymus dependence of rat CD8 isoform expression. Eur. J. Immunol. 22: 2841.
36. WARD, J. M., and C. W. REYNOLDS. 1983. Large granular lymphocytes leukemia. A heterogeneous lymphocytic leukemia in F344 rats. Am. J. Pathol. 111: 1.